Since the year of 2021, the world has entered the post-epidemic era. Although vaccines are widely available and provide much-needed protection, the continued spread of new variants of the virus continue to bring indirect challenges such as the rise of raw material costs, port congestion of transported goods, and production capacity interruptions.
However, the company regards challenges as opportunities, and flexibly responds to all kind s of new trends after the epidemic through production capacity allocation and product sales strategies. Thanks to the efforts exerted by all of our employees, the company was able to achieve outstanding financial performance in 2021, with consolidated revenue and after-tax earnings per share hitting record highs, fully demonstrating the company’s continuous improvement of product core competitiveness, active and effective management while displaying the determination to create the company’s sustainable development and growth.
Meanwhile, the company is also taking initiative in working on environmental, social and governance (ESG) issues related to sustainable development. In 2021, we carried out a number of sustainable action plans through “deepening corporate governance and implementing risk control”, “promoting green and innovative products and marching towards a sustainable economy”, and “practicing continuous social care based on humanism” in hopes of building a better and more sustainable environment and society with our core advantages.